Skip to main content
OpenTrials

Clinical trial condition

Focal Segmental Glomerulosclerosis

Explore clinical trials studying Focal Segmental Glomerulosclerosis. Study availability and eligibility vary by location and protocol.

42 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Focal Segmental Glomerulosclerosis trial results

Completed

Kidney Disease Biomarkers

NCT00255398

Conditions
Collapsing Glomerulopathy, Diabetes Complications, Diabetes Mellitus, +22 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial

NCT00814255

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +7 more
Locations
  • University of Miami Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Kansas Kansas City, Kansas, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 18 locations
View Trial Details
Completed

Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS

NCT00464321

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +7 more
Locations
  • San Francisco, California, United States
  • Rochester, Minnesota, United States
  • New Hyde Park, New York, United States
  • Chapel Hill, North Carolina, United States
View Trial Details
Active, Not Recruiting

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

NCT07219121

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cornell Medical Center New York, United States
  • University of North Carolina Chapel Hill Morrisville, North Carolina, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details

Related conditions